CRISPR Therapeutics AG

( )
CRSP After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -3.97%152.680.0%$1912.42m
OCGNOcugen, Inc. -13.03%8.610.0%$1021.08m
BNTXBioNTech SE -6.00%186.130.0%$842.08m
AMGNAmgen, Inc. -0.58%250.831.3%$707.44m
SNSSSunesis Pharmaceuticals, Inc. 3.73%9.190.7%$642.41m
NVAXNovavax, Inc. -7.50%127.8279.8%$550.05m
GILDGilead Sciences, Inc. 0.34%67.451.0%$478.20m
ALXNAlexion Pharmaceuticals, Inc. 0.34%171.992.0%$414.30m
REGNRegeneron Pharmaceuticals, Inc. 1.19%507.142.7%$408.92m
VRTXVertex Pharmaceuticals, Inc. -0.15%212.681.9%$313.21m
ILMNIllumina, Inc. -2.27%372.843.5%$292.44m
BIIBBiogen, Inc. -1.57%274.021.7%$254.68m
VXRTVaxart, Inc. -5.10%6.510.0%$234.99m
CRSPCRISPR Therapeutics AG -2.61%100.840.6%$160.77m
SGENSeagen Inc. 4.10%144.775.8%$133.21m

Company Profile

CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan and Craig Mellow in 2014 and is headquartered in Zug, Switzerland.